ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,267.84
      -0.74%
      US Tech 100
      18,152.00
      -0.42%
      Dow Jones
      39,065.26
      -1.53%
      Brent Oil
      81.175
      -0.17%
      Bitcoin
      67,907.13
      -0.03%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Entrada Therapeutics Inc (TRDA)

      7. Entrada Therapeutics Inc (TRDA) Financials

      TRDA Entrada Therapeutics Inc

      15.02
      -0.99 (-6.18%)
      May 23 2024 - Closed
      Delayed by 15 minutes

      Statistics

      Annual Quarterly
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Return on Assets (%) -33.455-33.919-1.854
      Return on Equity (%) -34.252-37.012-2.939
      Return on Invested Capital (%) -34.331-38.803-9.978
      Operating Margin (%) N/A N/A 9.345
      Net Profit Margin (%) N/A N/A -5.182
      Book Value Per Share 9.5676.777.263
      Earnings Per Share -1.638-3.014-0.2
      Cash Per Share 9.3221.4382.026
      Working Capital Per Share 9.3515.9856.323
      Operating Profit Per Share N/A N/A 3.866
      EBIT Per Share -1.638-3.0140.361
      EBITDA Per Share -1.638-3.0140.361
      Free Cash Flow Per Share -1.527-2.982-0.117

      Liquidity Ratios

      Year End December 30 2023 202120222023
      Current Ratio 44.4569.5522.329
      Quick Ratio 43.328.5892.216
      Inventory Turnover (Days) N/A N/A N/A
      Shares Outstanding 31.22M31.4MN/A

      Key Stats and Ratios

      Year End December 30 2023 Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)
      Shares Outstanding N/AN/A31.33M31.4MN/A33.21MN/AN/A
      Return on Assets (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Return on Equity (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Return on Invested Capital (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Operating Margin (%) N/A N/A N/A N/A -12.363 N/A N/A N/A
      Net Profit Margin (%) N/A N/A N/A N/A -26.421 N/A N/A N/A
      Sales Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Book Value Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Earnings Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Cash Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Working Capital Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Operating Profit Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      EBIT Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      EBITDA Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Free Cash Flow Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Current Ratio 17.679 N/A N/A N/A 2.941 N/A N/A N/A
      Quick Ratio 17.108 N/A N/A N/A 2.789 N/A N/A N/A
      Inventory Turnover (Days) N/A N/A N/A N/A N/A N/A N/A N/A

      Key Stats and Ratios

      Market Cap 506.7M
      Price to Earnings Ratio -75.78
      Price to Sales Ratio 3.93
      Price to Cash Ratio 7.5
      Price to Book Ratio 2.09
      Dividend Yield -

      Share Statistics

      Shares Outstanding 33.6M
      Average Volume (1 week) 85.18k
      Average Volume (1 Month) 67.43k
      52 Week Change 15.01%
      52 Week High 18.44
      52 Week Low 10.62
      More Ratios Coming Soon!

      Your Recent History

      NASDAQ
      TRDA
      Entrada Therapeutics
      Delayed Upgrade Clock